Year: 2023
Type: editorial
Abstract: With the activity of adjuvant immunotherapy, is sentinel lymph node biopsy still needed in melanoma?
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.23.00255
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Alnylam Pharmaceuticals, RefleXion Medical, Array BioPharma, Regeneron Pharmaceuticals, Tizona Therapeutics, Kowa Company, Agios Pharmaceuticals, Mersana Therapeutics, Mirati Therapeutics, Incyte, Ribon Therapeutics, Moderna, MacroGenics, Castle Biosciences, Seagen, Rakuten Medical, Coherus Biosciences, Eisai, Astellas Pharma, Galderma, Servier, LEO Pharma, Genentech, EMD Serono, National Cancer Institute, National Institute of Dental and Craniofacial Research
OpenAlex ID: W4383314426